Showing results (71-80 of 496) with videos related to
Sort By:
Pageof 50
British Journal of Clinical Pharmacology|November 26, 2002
Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German populationMaria Burian, Sabine Grösch, Irmgard Tegeder, et al.Mutation Research. Reviews in Mutation Research|March 14, 2012
The pharmacogenetic background of hepatitis C treatmentChristina Schlecker, Alfred Ultsch, Gerd Geisslinger, et al.Pharmacological Reviews|March 26, 2011
SNO-ing at the nociceptive synapse?Irmgard Tegeder, Reynir Scheving, Ilka Wittig, et al.European Journal of Clinical Pharmacology|November 25, 2005
Rapid genotyping for relevant CYP1A2 alleles by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.Clinical Pharmacokinetics|February 5, 2002
Drug interactions with patient-controlled analgesiaJorn Lotsch, Carsten Skarke, Irmgard Tegeder, et al.Lancet (London, England)|April 24, 2010
Ziconotide for treatment of severe chronic painAchim Schmidtko, Jörn Lötsch, Rainer Freynhagen, et al.Cellular Signalling|October 11, 2011
Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1Klaus Deckmann, Florian Rörsch, Gerd Geisslinger, et al.Nature Reviews. Neurology|November 5, 2014
Mechanism-based treatment for chemotherapy-induced peripheral neuropathic painMarco Sisignano, Ralf Baron, Klaus Scholich, et al.Molecular Biosystems|February 24, 2012
Identification of DNA-protein complexes using an improved, combined western blotting-electrophoretic mobility shift assay (WEMSA) with a fluorescence imaging systemKlaus Deckmann, Florian Rörsch, Gerd Geisslinger, et al.Nature Reviews. Drug Discovery|April 2, 2009
Capturing adenylyl cyclases as potential drug targetsSandra Pierre, Thomas Eschenhagen, Gerd Geisslinger, et al.Pageof 50